Gene sequencing is a procedure in which the nucleotides are identified in the DNA of an organism. This method is used to learn about the genome of the organism as a whole and to identify specific areas of interest or required. Low cost, precise results, high accuracy, and rapid results are the key features of gene sequencing technique. Gene sequencing is used to execute various applications such as oncology studies, reproductive health, clinical investigation, and others. It consists of widely replaced conventional tools of genomics, especially, microarray, genotyping, and others. Maxam-Gilbert Sequencing and Sanger Sequencing are the types of gene sequencing.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Owing to such factors, COVID 19 is expected to have a significant impact on the gene sequencing market.
Top Impacting Factors
- Increase in number of genome mapping programs across the globe, rise in demand by oncology department, surge in awareness regarding early diagnosis & detection of chronic diseases, and rise in next generation sequencing in diagnostic procedures are the key factors that drive the growth of the market.
- In addition, launch of novel third generation sequencing procedure such as Nanopore & Single- Molecule Real-Time sequencing, continuous technological innovations in sequencing market through R & D activities, surge in adoption of highly advanced diagnostic tests, rise in demand of cost effective diagnostic procedures, and joint ventures & agreements between key market players are expected to boost the growth of the market.
- However, lack of awareness regarding sequencing diagnostic tests can hinder the growth of the market.
- Contrarily, government support through product approval and improved reimbursement policies for diagnostic tests are expected to offer lucrative opportunities for the expansion of the market.
Market Trends
New Product Launches to Flourish the Market
In 2021, Centogene announced launch of its new CentoXome product. This product is used full in whole exome sequencing procedures in gene. Moreover, rare and complicated or unsolved diseases can be diagnosed with the help of this product.
In 2019, Thermo Fisher Scientific launched Ion Torrent Genexus System. This product is fully integrated next generation sequencing featuring specimen to report workflow and delivers results economically in a single day. This product can be used in DNA mutation analysis and RNA fusion transcripts in myeloid samples.
Key Benefits of the Report
- This study presents the analytical depiction of gene sequencing market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Gene Sequencing Market Report
- Which are the leading players active in the gene sequencing market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "gene sequencing"?
- What is "gene sequencing" market prediction in the future?
- Who are the leading global players in the "gene sequencing" market?
- What are the current trends and predicted trends?
- What are the key benefits of the "gene sequencing" market report?
Gene Sequencing Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Application |
|
 By Workflow Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | QIAGEN, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Intrexon Bioinformatics Germany GmbH, PierianDx, F. Hoffmann-La Roche Ltd., Myriad Genetics, Pacific Biosciences of California, Inc. |
Loading Table Of Content...
